Media contacts

Iryna Mazur
+41 79 429 3671
+41 22 909 2920
imazur@gavi.org

Iryna Mazur

 

James Fulker
+41 79 429 5505
jfulker@gavi.org
 

James Fulker

 

Meghana Sharafudeen
+41 79 711 5554
msharafudeen@gavi.org
 

Meghana Sharafudeen

 

Evan O’Connell
+33 6 17 57 21 26
+41 22 909 6528
eoconnell@gavi.org

Evan O’Connell

Latest news releases

View all

Around 450,000 girls aged 9-10 will receive the human papillomavirus (HPV) vaccine, which protects against the leading cause of cervical cancer. Myanmar currently has the second-highest incidence of cervical cancer in Southeast Asia.

Japanese Government pledges US$ 130 million in funding to the Gavi COVAX Advance Market Commitment (AMC), bringing the total raised to roughly US$ 1.8 billion.

The United Kingdom, Canada, Germany, Italy and Sweden pledge approximately US$ 960 million to Gavi’s COVID-19 Vaccines Advance Market Commitment (COVAX AMC)

The Gavi Board has approved the provision of US$ 150 million in initial funding to jumpstart support COVAX AMC-eligible countries’ readiness to deliver COVID-19 vaccines, in the form of planning, technical assistance and cold chain equipment

Collaboration among the Serum Institute of India (SII), Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation will accelerate manufacturing and delivery of up to an additional 100 million doses of future vaccines, if proven to be…

Media resources | assets

If you would you like to receive updates from the Gavi media team, or request access to our digital library of high-resolution images and B-roll, please email media@gavi.org.

Facts and figures

GAVI/2017/Guido Dingemans/Mozambique

Gavi factsheet: about the Vaccine Alliance

Gavi factsheet: about the Vaccine Alliance

Types of support

GAVI/2017/Juliette Bastin/Burkina Faso

Country hub

Country hub

Gavi leadership

 

Dr Ngozi Okonjo-Iweala
Board Chair

Dr Ngozi Okonjo-Iweala

Dr Seth Berkley
CEO

Seth Berkley, Gavi CEO. Credit: Gavi/Oscar Seijkens.

Anuradha Gupta
Deputy CEO

Anuradha Gupta
Last updated: 19 Oct 2020

Subscribe to our newsletter